Article
05 May 2026
SEC Proposes Optional Semiannual Reporting On New Form 10-S
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
27 Apr 2026
Cannabis Rescheduling: DOJ, Treasury, And DEA Updates Since The April 23 Order
Article
24 Apr 2026
SEC Issues Exemptive Order Permitting Shortened Tender Offer Periods
Article
23 Apr 2026
DOJ Immediately Reschedules State-Licensed Medical Cannabis To Schedule III — And Restarts The Clock On Broader Rescheduling
Article
23 Apr 2026
DOJ Immediately Reschedules State-Licensed Medical Cannabis To Schedule III — And Restarts The Clock
Article
23 Mar 2026
Wall Street Journal Reports That SEC Is Preparing A Proposal To Eliminate Mandatory Quarterly Reporting Requirements
Article
17 Mar 2026
SEC Extends Section 16(a) Reporting To FPI Directors And Officers And Grants Conditional Relief In Six Jurisdictions
Article
27 Feb 2026
Change On The Way: SEC Reiterates Commitment To Disclose Reform
Article
23 Jan 2026
Key Themes From The 2026 J.P. Morgan Healthcare Conference: Evidence, Execution And Emerging Momentum
Article
14 Jan 2026
2026 J.P. Morgan Healthcare Conference Preview: Dealmaking, Capital, And Strategic Themes To Watch
Article
09 Jan 2026
JPMorgan's Split With Proxy Advisers: A Harbinger For The 2026 Proxy Season
Article
20 Nov 2025
White House Weighing Limits On Proxy Advisers And Index-Fund Voting
Article
19 Jun 2025
SEC Issues Concept Release Soliciting Public Comment On Foreign Private Issuer Definition
Article
22 May 2025
SEC Issues New C&DIs Re: Compensation Clawback Disclosures And De-SPACs
Article
04 Apr 2025
SEC Announces $3.8 Million In Penalties In Continued Enforcement Sweep Of Late Beneficial Ownership And Insider Transaction Reports
Article
03 Apr 2025
Congress Considering Securities Offering Reform To Encourage Capital Formation
Article
17 Dec 2024
2024 OASB Report On IPO Activity And Small Public Companies
Article
23 Aug 2024
Biotech Public Markets Finally Thawing(?): Two Massachusetts Biotechs File S-1s
Article
15 Mar 2024
SEC Adopts Final Rules Regarding Climate-Related Disclosures
Article
21 Feb 2024
SEC Adopts Final Amendments To Schedule 13D And 13G Requirements